ROCHESTER, N.Y., May 7, 2012 (GLOBE NEWSWIRE) -- NaturalNano, Inc. (OTCBB:NNAN) announced that the US Patent & Trademark Office had granted the Company a patent application covering the use of its proprietary Halloysite NanoTubes (HNT) as a key strengthening component to enhance the performance of Polymeric Composite materials including Nano-particle Fillers.
NaturalNano's CEO James Wemett commented, "We continue our efforts to expand and protect the commercial applications for our HNT. In this important patent application, the Patent Office granted NNAN protection for the use of HNT as a key strengthening agent for use in Polymeric Composites. Our patent portfolio continues to grow which strengthens our position as the world leader in the industrial applications for Halloysite as we continue to expand our licensing opportunities."
About NaturalNano, Inc.:
NaturalNano, Inc. (OTCBB:NNAN) is a materials science company focused on developing and commercializing advanced nanocomposites. The Company is focused on additive technologies and processes, including its proprietary Pleximer that adds value to industrial polymers, plastics and composites. NaturalNano holds and/or licenses 20 patents and applications relating to Halloysite, as well as proprietary know-how for its extraction and separation processes, compositions, and derivatives. http://www.naturalnano.com/">www.naturalnano.com
Cautionary Statement Regarding Forward-Looking Statements: Contains forward-looking statements regarding future events and future performance that involve risks and uncertainties that could materially affect actual results. This information is qualified in its entirety by cautionary statements and risk factors disclosure contained in certain of NaturalNano's filings with the Securities and Exchange Commission. The most recent annual reports on Form 10-K and quarterly reports on Form 10-Q filed by NaturalNano provide information about these factors, which may be revised or supplemented in future reports to the SEC on those forms or on Form 8-K. We caution investors not to place undue reliance on forward-looking statements, and we do not undertake any obligation to update or otherwise revise any forward-looking statements, whether as a result of new information, future events, or other such factors that affect the subject of these statements, except where expressly required by law.